Connection

Ayad Jaffa to Rats

Back to Details
This is a "connection" page, showing publications Ayad Jaffa has written about Rats.
Ayad Jaffa
Connection Strength
1.284
Rats
  1. Heteromerization fingerprints between bradykinin B2 and thromboxane TP receptors in native cells. PLoS One. 2019; 14(5):e0216908.
    View in: PubMed
    Score: 0.093
  2. Proteome profiling in the aorta and kidney of type 1 diabetic rats. PLoS One. 2017; 12(11):e0187752.
    View in: PubMed
    Score: 0.084
  3. Mechanisms of bradykinin-induced expression of connective tissue growth factor and nephrin in podocytes. Am J Physiol Renal Physiol. 2015 Dec 01; 309(11):F980-90.
    View in: PubMed
    Score: 0.072
  4. Novel mechanism of plasma prekallikrein (PK) activation by vascular smooth muscle cells: evidence of the presence of PK activator. J Biol Regul Homeost Agents. 2014 Oct-Dec; 28(4):587-603.
    View in: PubMed
    Score: 0.068
  5. Creatinine metabolite, HMH (5-hydroxy-1-methylhydantoin; NZ-419), modulates bradykinin-induced changes in vascular smooth muscle cells. J Recept Signal Transduct Res. 2014 Jun; 34(3):195-200.
    View in: PubMed
    Score: 0.065
  6. The arrestin-selective angiotensin AT1 receptor agonist [Sar1,Ile4,Ile8]-AngII negatively regulates bradykinin B2 receptor signaling via AT1-B2 receptor heterodimers. J Biol Chem. 2013 Jun 28; 288(26):18872-84.
    View in: PubMed
    Score: 0.061
  7. Low-density lipoprotein induced expression of connective tissue growth factor via transactivation of sphingosine 1-phosphate receptors in mesangial cells. Mol Endocrinol. 2012 May; 26(5):833-45.
    View in: PubMed
    Score: 0.057
  8. Plasma kallikrein promotes epidermal growth factor receptor transactivation and signaling in vascular smooth muscle through direct activation of protease-activated receptors. J Biol Chem. 2010 Nov 05; 285(45):35206-15.
    View in: PubMed
    Score: 0.051
  9. Evidence for prostacyclin and cAMP upregulation by bradykinin and insulin-like growth factor 1 in vascular smooth muscle cells. J Recept Signal Transduct Res. 2010 Apr; 30(2):61-71.
    View in: PubMed
    Score: 0.049
  10. Evidence for low-density lipoprotein-induced expression of connective tissue growth factor in mesangial cells. Kidney Int. 2005 Apr; 67(4):1286-96.
    View in: PubMed
    Score: 0.035
  11. Mechanisms through which bradykinin promotes glomerular injury in diabetes. Am J Physiol Renal Physiol. 2005 Mar; 288(3):F483-92.
    View in: PubMed
    Score: 0.035
  12. Mechanisms of angiotensin II-induced expression of B2 kinin receptors. Am J Physiol Heart Circ Physiol. 2004 Mar; 286(3):H926-32.
    View in: PubMed
    Score: 0.032
  13. Role of reactive oxygen species in bradykinin-induced proliferation of vascular smooth muscle cells. Biol Res. 2004; 37(3):419-30.
    View in: PubMed
    Score: 0.032
  14. Diabetes modulates the expression of glomerular kinin receptors. Int Immunopharmacol. 2002 Dec; 2(13-14):1771-9.
    View in: PubMed
    Score: 0.030
  15. Induction of B(1)-kinin receptors in vascular smooth muscle cells: cellular mechanisms of map kinase activation. Hypertension. 2001 Sep; 38(3 Pt 2):602-5.
    View in: PubMed
    Score: 0.027
  16. Regulation of B(2)-kinin receptors by glucose in vascular smooth muscle cells. Am J Physiol Heart Circ Physiol. 2001 Apr; 280(4):H1537-46.
    View in: PubMed
    Score: 0.026
  17. Mechanisms by which bradykinin promotes fibrosis in vascular smooth muscle cells: role of TGF-beta and MAPK. Am J Physiol Heart Circ Physiol. 2000 Dec; 279(6):H2829-37.
    View in: PubMed
    Score: 0.026
  18. Native and modified LDL activate extracellular signal-regulated kinases in mesangial cells. Diabetes. 2000 Dec; 49(12):2160-9.
    View in: PubMed
    Score: 0.026
  19. Role of reactive oxygen species in bradykinin-induced mitogen-activated protein kinase and c-fos induction in vascular cells. Hypertension. 2000 Apr; 35(4):942-7.
    View in: PubMed
    Score: 0.025
  20. Calcium-calmodulin mediates bradykinin-induced MAPK phosphorylation and c-fos induction in vascular cells. Am J Physiol. 1999 09; 277(3):H1061-8.
    View in: PubMed
    Score: 0.024
  21. Mechanisms of MAPK activation by bradykinin in vascular smooth muscle cells. Am J Physiol. 1999 08; 277(2):C253-61.
    View in: PubMed
    Score: 0.024
  22. Cellular distribution of exogenous aprotinin in the rat kidney. Biol Chem. 1998 Oct; 379(10):1271-7.
    View in: PubMed
    Score: 0.022
  23. Induction of renal kallikrein and renin gene expression by insulin and IGF-I in the diabetic rat. Diabetes. 1997 Dec; 46(12):2049-56.
    View in: PubMed
    Score: 0.021
  24. Bradykinin induces tubulin phosphorylation and nuclear translocation of MAP kinase in mesangial cells. Am J Physiol. 1997 12; 273(6):F916-24.
    View in: PubMed
    Score: 0.021
  25. Modulation of renal kallikrein production by dietary protein in streptozotocin-induced diabetic rats. J Am Soc Nephrol. 1996 May; 7(5):721-7.
    View in: PubMed
    Score: 0.019
  26. Skeletal muscle kallikrein. Potential role in metabolic regulation. Diabetes. 1996 Jan; 45 Suppl 1:S20-3.
    View in: PubMed
    Score: 0.018
  27. Characterization of the Kallikrein-Kinin System Post Chemical Neuronal Injury: An In Vitro Biochemical and Neuroproteomics Assessment. PLoS One. 2015; 10(6):e0128601.
    View in: PubMed
    Score: 0.018
  28. Kinin, a mediator of diabetes-induced glomerular hyperfiltration. Diabetes. 1995 Feb; 44(2):156-60.
    View in: PubMed
    Score: 0.017
  29. Insulin-like growth factor I produces renal hyperfiltration by a kinin-mediated mechanism. Am J Physiol. 1994 Jan; 266(1 Pt 2):F102-7.
    View in: PubMed
    Score: 0.016
  30. 20-HETE and EETs in diabetic nephropathy: a novel mechanistic pathway. PLoS One. 2013; 8(8):e70029.
    View in: PubMed
    Score: 0.016
  31. Altered renal kallikrein and renin gene expression in nephrotic rats and modulation by converting enzyme inhibition. J Clin Invest. 1993 Aug; 92(2):1073-9.
    View in: PubMed
    Score: 0.016
  32. Involvement of renal cytochromes P450 and arachidonic acid metabolites in diabetic nephropathy. J Biol Regul Homeost Agents. 2013 Jul-Sep; 27(3):693-703.
    View in: PubMed
    Score: 0.015
  33. Evidence for renal kinins as mediators of amino acid-induced hyperperfusion and hyperfiltration in the rat. J Clin Invest. 1992 May; 89(5):1460-8.
    View in: PubMed
    Score: 0.014
  34. Effects of diabetes and insulin on expression of kallikrein and renin genes in the kidney. Kidney Int. 1992 Apr; 41(4):789-95.
    View in: PubMed
    Score: 0.014
  35. Regulation of renal kallikrein synthesis and activation by glucocorticoids. Kidney Int. 1990 Aug; 38(2):212-8.
    View in: PubMed
    Score: 0.013
  36. Renal kallikrein responses to dietary protein: a possible mediator of hyperfiltration. Kidney Int. 1989 Dec; 36(6):1003-10.
    View in: PubMed
    Score: 0.012
  37. The effects of diabetes and insulin on colonic tissue kallikrein. Adv Exp Med Biol. 1989; 247B:669-73.
    View in: PubMed
    Score: 0.011
  38. Abnormal regulation of renal kallikrein in experimental diabetes. Effects of insulin on prokallikrein synthesis and activation. J Clin Invest. 1987 Dec; 80(6):1651-9.
    View in: PubMed
    Score: 0.011
  39. Studies of the effects of insulin, bradykinin, and captopril on blood glucose levels of alloxan-diabetic rats. Adv Exp Med Biol. 1986; 198 Pt B:373-8.
    View in: PubMed
    Score: 0.009
  40. A comparative study of prokallikreins and kallikreins from rat pancreatic tissue and juice. Adv Exp Med Biol. 1986; 198 Pt A:323-7.
    View in: PubMed
    Score: 0.009
  41. Utilization of a radioimmunoassay to detect the generation of Arg-Pro-Pro-Gly-Phe, a stable endproduct of bradykinin metabolism (from cultured rat aortic smooth muscle cells exposed to bradykinin). Int Immunopharmacol. 2002 Dec; 2(13-14):1995-2003.
    View in: PubMed
    Score: 0.007
  42. Lipids stimulate the production of 6-keto-prostaglandin f(1alpha) in human dorsal hand veins. Hypertension. 2001 Oct; 38(4):858-63.
    View in: PubMed
    Score: 0.007
  43. A metabolic fragment of bradykinin, Arg-Pro-Pro-Gly-Phe, protects against the deleterious effects of lipopolysaccharide in rats. J Pharmacol Exp Ther. 2001 Jan; 296(1):71-6.
    View in: PubMed
    Score: 0.007
  44. Oleic acid and angiotensin II induce a synergistic mitogenic response in vascular smooth muscle cells. Hypertension. 1998 Apr; 31(4):978-85.
    View in: PubMed
    Score: 0.005
  45. Role of kinins in the renal response to enalaprilat in normotensive and hypertensive rats. Hypertension. 1996 Feb; 27(2):235-44.
    View in: PubMed
    Score: 0.005
  46. Rat renal interstitial bradykinin, prostaglandin E2, and cyclic guanosine 3',5'-monophosphate. Effects of altered sodium intake. Hypertension. 1994 Jun; 23(6 Pt 2):1068-70.
    View in: PubMed
    Score: 0.004
  47. Thromboxane A2/prostaglandin H2 receptors in streptozotocin-induced diabetes: effects of insulin therapy in the rat. Prostaglandins. 1993 May; 45(5):427-38.
    View in: PubMed
    Score: 0.004
  48. Renal hyperfiltration states: relationship to kallikrein and kinins. Agents Actions Suppl. 1992; 38 ( Pt 3):142-8.
    View in: PubMed
    Score: 0.003
  49. Renal kallikrein and hemodynamic abnormalities of diabetic kidney. Diabetes. 1990 Mar; 39(3):299-304.
    View in: PubMed
    Score: 0.003
  50. Measurement of glomerular filtration rate and renal plasma flow in the diabetic rat by the single-injection isotopic technique: effects of altered distribution volumes of 51Cr-EDTA and 125I-hippuran. Diabetes Res. 1988 Oct; 9(2):67-72.
    View in: PubMed
    Score: 0.003
  51. A time-course study of submandibular kallikrein, blood glucose and insulin of alloxan-diabetic and streptozotocin-diabetic rats. Agents Actions. 1984 Dec; 15(5-6):478-81.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.